AndersonL., EdsmyrF., JönssonG., KönyvesI.: Estramustin phosphate therapy in carcinoma of the prostate. In: Recent results in cancer research, GrundmannE., VahlensieckW. Ed., p. 73, Springer Verlag, Berlin1977.
2.
BaloghF., KisbenedekL.: Treatment of prostatic cancer with Estracyt. Intern. Urol. & Nephrol., 7; 135 (1975).
3.
HedlundP. O., GustafssonH., SjögrenS.: Cardiovascular complications to treatment of prostatic cancer with estramustin phosphate (Estracyt) or conventional estrogen. Scand. J. Urol. & Nephrol., Suppl.55; 103 (1981).
4.
KokolchookV., BalterS.: Topometric, roentgenologic, laboratory and clinical criteria of tumour regression in conservative management of prostatic carcinoma. Scand. J. Urol. & Nephrol., Suppl.55; 75 (1981).
5.
LindbergB.: Treatment of rapidly progressing prostatic carcinoma with Estracyt. J. Urol., 108; 303 (1972).
6.
MittelmannA., SchuklaS. K., MurphyG. P.: Extended therapy of stage carcinoma of the prostate with oral estramustin phosphate. J. Urol., 115; 409 (1976).
